Effect of budesonide and salbutamol on surfactant properties

Journal of Applied Physiology

Volumn 89, Issue 3, 2000, Pages 884-890

  Palmer, D ^a   Schurch S ^a   Belik, J ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

Bovine lipid extract surfactant; Inhalant drugs; Rat; Survanta

Indexed keywords

BUDESONIDE; LIPID; LUNG SURFACTANT EXTRACT; SALBUTAMOL; SURFACTANT;

ADSORPTION; ARTICLE; BIOPHYSICS; COMPRESSION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FILM; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURFACE TENSION; TIME;

EID: 0034491747     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.2000.89.3.884     Document Type: Article

References (38)

1. Relations among alveolar surface tension, surface area, volume, and recoil pressure
2. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants
3. Effect of aerosol delivery system and formulation on nebulized budesonide output
4. Effect of oral and inhaled salbutamol in infants with bronchiolitis
5. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia
6. Budesonide inhalation powder: A review of its pharmacologic properties and role in the treatment of asthma
7. Biophysical alteration of lung surfactant by extracts of cotton dust
8. Dose-related bronchodilator response to aerosolized salbutamol (albuterol) in ventilator-dependent premature infants
9. Inhaled salbutamol and beclomethasone for preventing broncho-pulmonary dysplasia: A randomised double-blind study
10. Minimal surface tension, squeeze-out and transition temperatures of binary mixtures of dipalmitoyl phosphatidylcholine and unsaturated phospholipids
11. Physiologic and toxicologic responses of alveolar type II cells
12. Variations in predicted regional lung deposition of salbutamol sulphate between 19 nebulizer types
13. Delivery of salbutamol to nonventilated preterm infants by metered-dose inhaler, jet nebulizer, and ultrasonic nebulizer
14. Randomised crossover trial of salbutamol aerosol delivered by metered dose inhaler, jet nebuliser, and ultrasonic nebuliser in chronic lung disease
15. Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia
16. Effects of salbutamol delivery from a metered dose inhaler versus jet nebulizer on dynamic lung mechanics in very preterm infants with chronic lung disease
17. Amphotericin B and pulmonary surfactant
18. Lung surfactant and pulmonary toxicology
19. Natural vs. synthetic surfactants in neonatal respiratory distress syndrome
20. Bronchodilator responsiveness testing using raised volume forced expiration in recurrently wheezing infants
21. Short-time response characteristics of salbutamol in infants with broncho-pulmonary diseases
22. Bronchodilator aerosol administered by metered dose inhaler and spacer in subacute neonatal respiratory distress syndrome
23. Inhaled budesonide in ventilator-dependent preterm infants: A randomized, double-blind pilot study
24. Adverse effects of toxins and drugs on the surfactant systems
25. Role of the palmitoylation of surfactant-associated protein C in surfactant film formation and stability
26. The captive bubble method for the evaluation of pulmonary surfactant: Surface tension, area, and volume calculations
27. Surface tension at low lung volumes: Dependence on time and alveolar size
28. Surface tension properties of surfactant
29. Surface properties of rat pulmonary surfactant studied with the captive bubble method: Adsorption, hysteresis, stability
30. A captive bubble method reproduces the in situ behavior of lung surfactant monolayers
31. Influence of calcium, cholesterol, and unsaturation on lecithin monolayers
32. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma
33. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma
34. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction
35. Aerosolized budesonide in asthmatic infants: A double blind study
36. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: A controlled comparative study with oral prednisolone
37. Effect of pulmonary surfactant protein A (SP-A) and calcium on the adsorption of cholesterol and film stability
38. Variable response to bronchodilator therapy in young children born prematurely